Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 5
2020 4
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Vitamin B12 Intake From Animal Foods, Biomarkers, and Health Aspects.
Obeid R, Heil SG, Verhoeven MMA, van den Heuvel EGHM, de Groot LCPGM, Eussen SJPM. Obeid R, et al. Among authors: verhoeven mma. Front Nutr. 2019 Jun 28;6:93. doi: 10.3389/fnut.2019.00093. eCollection 2019. Front Nutr. 2019. PMID: 31316992 Free PMC article. Review.
Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate.
Verhoeven MMA, Tekstra J, Welsing PMJ, Pethö-Schramm A, Borm MEA, Bruyn GAW, Bos R, Griep EN, Klaasen R, van Laar JM, Lafeber FPJG, Bijlsma JWJ, de Hair MJH, Jacobs JWG. Verhoeven MMA, et al. Rheumatology (Oxford). 2020 Sep 1;59(9):2325-2333. doi: 10.1093/rheumatology/kez602. Rheumatology (Oxford). 2020. PMID: 31859346 Free PMC article. Clinical Trial.
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
Verhoeven MM, de Hair MJ, Tekstra J, Bijlsma JW, van Laar JM, Pethoe-Schramm A, Borm ME, Ter Borg EJ, Linn-Rasker SP, Teitsma XM, Lafeber FP, Jacobs JW, Welsing PM. Verhoeven MM, et al. Ann Rheum Dis. 2019 Oct;78(10):1333-1338. doi: 10.1136/annrheumdis-2019-215304. Epub 2019 Jun 13. Ann Rheum Dis. 2019. PMID: 31196844
Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis.
Besselink NJ, Westgeest AAA, Klaasen R, Gamala M, van Woerkom JM, Tekstra J, Verhoeven MMA, Van Spil WE, Lafeber FPJG, Marijnissen ACA, Van Laar JM, Jacobs JWG. Besselink NJ, et al. Among authors: verhoeven mma. Trials. 2019 Apr 17;20(1):226. doi: 10.1186/s13063-019-3285-8. Trials. 2019. PMID: 30999969 Free PMC article.
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.
Gosselt HR, Verhoeven MMA, de Rotte MCFJ, Pluijm SMF, Muller IB, Jansen G, Tekstra J, Bulatović-Ćalasan M, Heil SG, Lafeber FPJG, Hazes JMW, de Jonge R. Gosselt HR, et al. Among authors: verhoeven mma. Rheumatol Ther. 2020 Dec;7(4):837-850. doi: 10.1007/s40744-020-00230-7. Epub 2020 Sep 14. Rheumatol Ther. 2020. PMID: 32926395 Free PMC article.
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis.
Gosselt HR, Verhoeven MMA, Bulatović-Ćalasan M, Welsing PM, de Rotte MCFJ, Hazes JMW, Lafeber FPJG, Hoogendoorn M, de Jonge R. Gosselt HR, et al. Among authors: verhoeven mma. J Pers Med. 2021 Jan 14;11(1):44. doi: 10.3390/jpm11010044. J Pers Med. 2021. PMID: 33466633 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page